- Sprache
-
Englisch
- Identifier
-
1122350430
Thema
-; Endokrinologie
Beteiligte Personen und Organisationen
Jumar, Agnes
Harazny, Joanna M.
Ott, Christian
Friedrich, Stefanie
Kistner, Iris
Striepe, Kristina
Schmieder, Roland E.
Harazny, Joanna M.
Ott, Christian
Friedrich, Stefanie
Kistner, Iris
Striepe, Kristina
Schmieder, Roland E.
- URN
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
26.01.2023, 13:57 MEZ
Beteiligte
- Jumar, Agnes
- Harazny, Joanna M.
- Ott, Christian
- Friedrich, Stefanie
- Kistner, Iris
- Striepe, Kristina
- Schmieder, Roland E.
Ähnliche Objekte (12)
Effects of saxagliptin on early microvascular changes in patients with type 2 diabetes
Retinal capillary rarefaction in patients with untreated mild-moderate hypertension
A randomised study of the impact of the SGLT2 inhibitor dapagliflozin on microvascular and macrovascular circulation
How does empagliflozin improve arterial stiffness in patients with type 2 diabetes mellitus? Sub analysis of a clinical trial
Renal and intraglomerular haemodynamics in chronic heart failure with preserved and reduced ejection fraction
Vergleich verschiedener Kalziumantagonisten hinsichtlich ihrer Auswirkung auf die intrarenale Hämodynamik bei Patienten mit arterieller Hypertonie
Effekte von Linagliptin auf die renale Endothelfunktion bei Patienten mit Diabetes mellitus Typ 2
Early vascular parameters in the micro- and macrocirculation in type 2 diabetes
Achievement of individualized treatment targets in patients with comorbid type-2 diabetes and hypertension: 6 months results of the DIALOGUE registry
Review of direct renin inhibition by aliskiren
Neurogenic substance P—influences on action potential production in afferent neurons of the kidney?
Achievement of recommended glucose and blood pressure targets in patients with type 2 diabetes and hypertension in clinical practice – study rationale and protocol of DIALOGUE
Effects of saxagliptin on early microvascular changes in patients with type 2 diabetes
Retinal capillary rarefaction in patients with untreated mild-moderate hypertension
A randomised study of the impact of the SGLT2 inhibitor dapagliflozin on microvascular and macrovascular circulation
How does empagliflozin improve arterial stiffness in patients with type 2 diabetes mellitus? Sub analysis of a clinical trial
Renal and intraglomerular haemodynamics in chronic heart failure with preserved and reduced ejection fraction
Vergleich verschiedener Kalziumantagonisten hinsichtlich ihrer Auswirkung auf die intrarenale Hämodynamik bei Patienten mit arterieller Hypertonie
Effekte von Linagliptin auf die renale Endothelfunktion bei Patienten mit Diabetes mellitus Typ 2
Early vascular parameters in the micro- and macrocirculation in type 2 diabetes
Achievement of individualized treatment targets in patients with comorbid type-2 diabetes and hypertension: 6 months results of the DIALOGUE registry
Review of direct renin inhibition by aliskiren
Neurogenic substance P—influences on action potential production in afferent neurons of the kidney?
Achievement of recommended glucose and blood pressure targets in patients with type 2 diabetes and hypertension in clinical practice – study rationale and protocol of DIALOGUE
Effects of saxagliptin on early microvascular changes in patients with type 2 diabetes
Retinal capillary rarefaction in patients with untreated mild-moderate hypertension
A randomised study of the impact of the SGLT2 inhibitor dapagliflozin on microvascular and macrovascular circulation
How does empagliflozin improve arterial stiffness in patients with type 2 diabetes mellitus? Sub analysis of a clinical trial
Renal and intraglomerular haemodynamics in chronic heart failure with preserved and reduced ejection fraction
Vergleich verschiedener Kalziumantagonisten hinsichtlich ihrer Auswirkung auf die intrarenale Hämodynamik bei Patienten mit arterieller Hypertonie
Effekte von Linagliptin auf die renale Endothelfunktion bei Patienten mit Diabetes mellitus Typ 2
Early vascular parameters in the micro- and macrocirculation in type 2 diabetes
Achievement of individualized treatment targets in patients with comorbid type-2 diabetes and hypertension: 6 months results of the DIALOGUE registry
Review of direct renin inhibition by aliskiren
Neurogenic substance P—influences on action potential production in afferent neurons of the kidney?